Insider · CIK 0001688269
Jason Lettmann
Files at ALXO (ALX ONCOLOGY HOLDINGS INC). First filing Feb 21, 2025, latest Mar 23, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ALXO: ALX ONCOLOGY HOLDINGS INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 38Weak | ALX ONCOLOGY HOLDINGS INC | $27k 12,311 shares | -4% | +439% from low-16% from high | |
| 49Moderate | ALXObuy ALX ONCOLOGY HOLDINGS INC | $99k 92,233 shares | +43% | +166% from low-50% from high | |
| 33Weak | ALX ONCOLOGY HOLDINGS INC | $1,525 2,382 shares | -1% | +59% from low-71% from high | |
| 40Moderate | ALX ONCOLOGY HOLDINGS INC | $2,483 2,159 shares | -1% | +14% from low-46% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 19, 2026 | ALXO ALX ONCOLOGY HOLDINGS INC | SOpen-market sale Common Stock | -12,311 | $2.17 | $27k | 293,609 | Mar 23, 2026 |
| Feb 17, 2026 | ALXO ALX ONCOLOGY HOLDINGS INC | FTax withholding Common Stock | -2,201 | $2.27 | $4,996 | 305,920 | Feb 19, 2026 |
| Jan 26, 2026 | ALXO ALX ONCOLOGY HOLDINGS INC | AGrant or award Stock option (right to buy)derivative | +912,000 | $0.00 | $0 | 912,000 | Jan 28, 2026 |
| Oct 14, 2025 | ALXO ALX ONCOLOGY HOLDINGS INC | AGrant or award Employee Stock Option (right to buy)derivative | +597,500 | $0.00 | $0 | 597,500 | Oct 16, 2025 |
| Sep 16, 2025 | ALXO ALX ONCOLOGY HOLDINGS INC | POpen-market purchase Common Stock | +21,070 | $1.07 | $22k | 233,958 | Sep 18, 2025 |
| Sep 17, 2025 | ALXO ALX ONCOLOGY HOLDINGS INC | POpen-market purchase Common Stock | +71,163 | $1.08 | $77k | 305,121 | Sep 18, 2025 |
| Aug 15, 2025 | ALXO ALX ONCOLOGY HOLDINGS INC | SOpen-market sale Common Stock | -2,382 | $0.64 | $1,525 | 212,888 | Aug 19, 2025 |
| Apr 11, 2025 | ALXO ALX ONCOLOGY HOLDINGS INC | AGrant or award Employee Stock Option (right to buy)derivative | +125,000 | $0.00 | $0 | 125,000 | Apr 15, 2025 |
| Mar 14, 2025 | ALXO ALX ONCOLOGY HOLDINGS INC | AGrant or award Common Stock | +42,000 | $0.00 | $0 | 212,270 | Mar 18, 2025 |
| Feb 19, 2025 | ALXO ALX ONCOLOGY HOLDINGS INC | SOpen-market sale Common Stock | -2,159 | $1.15 | $2,483 | 170,270 | Feb 21, 2025 |
| Jan 21, 2025 | ALXO ALX ONCOLOGY HOLDINGS INC | AGrant or award Employee Stock Option (right to buy)derivative | +478,000 | $0.00 | $0 | 478,000 | Jan 23, 2025 |
| Dec 2, 2024 | ALXO ALX ONCOLOGY HOLDINGS INC | AGrant or award Employee Stock Option (right to buy)derivative | +200,000 | $0.00 | $0 | 200,000 | Dec 4, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.